Charlotte Retention in Care Study

Charlotte Retention in Care Study - Clinical Decision Support System Prompts

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03584048

Enrollment

6500

Registered

2018-07-12

Start date

2018-07-01

Completion date

2019-10-31

Last updated

2021-11-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV I Infection

Brief summary

The objective of the Charlotte Retention in Care study is to assess if clinical decision support systems (CDSS) that produce standardized alerts for measures of retention in care across clinics in the city of Charlotte, North Carolina have the ability to increase retention in care measures within clinics and in surveillance reports.

Detailed description

Multiple Charlotte HIV Clinic providers are participating. Primary HIV provider will be defined as the primary physician or advanced care practitioner following a patient, as recorded in their respective Electronic Health Record (EHR) system and identified through CHORUS, a Clinical Decision Support System (CDSS) developed by Epividian. The CDSS will track patient case status as active or inactive (loss to follow-up, transferred medical care, or deceased). Providers will be informed of the study and sites will be contracted to participate in this collaborative research study. This study was approved by the Advarra Institutional Review Board.

Interventions

OTHERAlert to provider

Providers receive alerts of sub-optimal patient attendance using 4 rules.

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* HIV-1+ * Any gender * 18 years old or older * Residing in the Charlotte, North Carolina metropolitan area * At least a single entry in the EHR in the last 2 years

Design outcomes

Primary

Measure	Time frame	Description
Engagement level	12 months, 01-Nov-2018 to 31-Oct-2019	Pre and post-baseline engagement level. Engagement level is defined as patients with 0, 1, or 2+ visits to physician (identified as a visit that included the collection of 1 viral load and/or 1 CD4 count lab test).

Secondary

Measure	Time frame	Description
Kept appointment	12 months, 01-Nov-2018 to 31-Oct-2019	Pre and post-baseline kept appointment rate, the proportion of patients who attended their scheduled office visits.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026